BANK OF AMERICA CORP /DE/ - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 97 filers reported holding G1 THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 1.35 and the average weighting 0.0%.

Quarter-by-quarter ownership
BANK OF AMERICA CORP /DE/ ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$415,102
-48.0%
288,265
-10.0%
0.00%
Q2 2023$797,661
-50.7%
320,346
-46.9%
0.00%
Q1 2023$1,617,161
+16.2%
603,418
+135.4%
0.00%
Q4 2022$1,392,067
-66.8%
256,366
-23.7%
0.00%
-100.0%
Q3 2022$4,196,000
+233.0%
335,954
+31.7%
0.00%
Q2 2022$1,260,000
-54.3%
255,053
-29.7%
0.00%
Q1 2022$2,756,000
-27.5%
362,573
-2.7%
0.00%
Q4 2021$3,804,000
+3.7%
372,700
+36.3%
0.00%
Q3 2021$3,669,000
-51.1%
273,365
-20.0%
0.00%
-100.0%
Q2 2021$7,496,000
+14.9%
341,638
+26.0%
0.00%0.0%
Q1 2021$6,523,000
+35.6%
271,138
+1.4%
0.00%0.0%
Q4 2020$4,809,000
+46.3%
267,314
-6.0%
0.00%
Q3 2020$3,286,000
-49.2%
284,476
+6.7%
0.00%
-100.0%
Q2 2020$6,466,000
+123.4%
266,549
+1.5%
0.00%0.0%
Q1 2020$2,894,000
-59.7%
262,577
-3.4%
0.00%0.0%
Q4 2019$7,183,000
+15.8%
271,796
-0.2%
0.00%0.0%
Q3 2019$6,203,000
-32.5%
272,337
-9.1%
0.00%0.0%
Q2 2019$9,188,000
+24.1%
299,649
-32.8%
0.00%0.0%
Q1 2019$7,404,000
+52.5%
445,977
+75.9%
0.00%0.0%
Q4 2018$4,855,000
-63.3%
253,579
+0.1%
0.00%
-50.0%
Q3 2018$13,245,000
+13.9%
253,298
-5.3%
0.00%0.0%
Q2 2018$11,624,000
+22.7%
267,471
+4.6%
0.00%0.0%
Q1 2018$9,470,000
+86.9%
255,594
+0.1%
0.00%
+100.0%
Q4 2017$5,066,000
+56188.9%
255,376
+69866.0%
0.00%
Q3 2017$9,0003650.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
Birchview Capital, LP 120,000$172,8000.15%
DENALI ADVISORS LLC 148,800$214,2720.08%
XTX Topco Ltd 296,601$427,1050.07%
NEEDHAM INVESTMENT MANAGEMENT LLC 234,000$336,9600.06%
LEVEL FOUR ADVISORY SERVICES, LLC 183,400$264,0960.02%
Curi Wealth Management, LLC 70,742$101,8690.02%
FRANKLIN STREET ADVISORS INC /NC 83,400$1200.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 140,000$201,6000.01%
JACOBS LEVY EQUITY MANAGEMENT, INC 573,256$825,4890.01%
ALGERT GLOBAL LLC 68,100$980.01%
View complete list of G1 THERAPEUTICS INC shareholders